This research highlights the metabolic effects of androgenic contraceptives, showing significant increases in postprandial ...

The U.K. will study whether Lilly's weight loss drug can get people back to work and help tackle long-term sickness ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a ...

The Food and Drug Administration said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high ...

Wegovy, the brand name for semaglutide, is only available as a weight-loss drug for people who are severely obese and living ...

A study will assess changes in employment status and sick days when people take the drug. Weight loss drugs could be given to unemployed people with obesity as a way of getting them into work, British ...

In her new memoir Vanessa Bares All, the TV personality delves deep into her childhood trauma and explains what led to her yo-yo dieting.

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Investors in weight-loss drug companies like Novo Nordisk and Eli Lilly face concerns over side effects and market ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...